Verus Financial Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $217K | Buy |
9,013
+21
| +0.2% | +$549 | 0.02% | 119 |
|
|
2026
Q1 | $245K | Hold |
8,992
| – | – | 0.02% | 112 |
|
|
2025
Q4 | $233K | Sell |
8,992
-1,552
| -15% | -$39.1K | 0.02% | 109 |
|
|
2025
Q3 | $269K | Buy |
10,544
+1,252
| +13% | +$30.9K | 0.03% | 103 |
|
|
2025
Q2 | $237K | Hold |
9,292
| – | – | 0.02% | 105 |
|
|
2025
Q1 | $209K | Hold |
9,292
| – | – | 0.02% | 100 |
|
|
2024
Q4 | $248K | Sell |
9,292
-225
| -2% | -$6.1K | 0.03% | 90 |
|
|
2024
Q3 | $273K | Hold |
9,517
| – | – | 0.03% | 88 |
|
|
2024
Q2 | $266K | Sell |
9,517
-687
| -7% | -$18.9K | 0.03% | 88 |
|
|
2024
Q1 | $283K | Hold |
10,204
| – | – | 0.03% | 84 |
|
|
2023
Q4 | $280K | Sell |
10,204
-796
| -7% | -$24.1K | 0.03% | 84 |
|
|
2023
Q3 | $353K | Buy |
11,000
+382
| +4% | +$13.5K | 0.05% | 66 |
|
|
2023
Q2 | $393K | Sell |
10,618
-4,785
| -31% | -$186K | 0.05% | 62 |
|
|
2023
Q1 | $589K | Sell |
15,403
-634
| -4% | -$27.4K | 0.08% | 54 |
|
|
2022
Q4 | $708K | Sell |
16,037
-18
| -0.1% | -$863 | 0.1% | 47 |
|
|
2022
Q3 | $708K | Sell |
16,055
-248
| -2% | -$12.1K | 0.11% | 42 |
|
|
2022
Q2 | $833K | Buy |
16,303
+645
| +4% | +$32.9K | 0.12% | 41 |
|
|
2022
Q1 | $832K | Buy |
15,658
+233
| +2% | +$12.1K | 0.12% | 39 |
|
|
2021
Q4 | $911K | Buy |
15,425
+1
| +0% | +$50 | 0.12% | 37 |
|
|
2021
Q3 | $637K | Buy |
15,424
+152
| +1% | +$6.73K | 0.1% | 43 |
|
|
2021
Q2 | $627K | Sell |
15,272
-293
| -2% | -$11.4K | 0.1% | 43 |
|
|
2021
Q1 | $559K | Buy |
15,565
+5
| +0% | +$178 | 0.09% | 42 |
|
|
2020
Q4 | $573K | Sell |
15,560
-12,943
| -45% | -$475K | 0.1% | 38 |
|
|
2020
Q3 | $992K | Buy |
28,503
+12,798
| +81% | +$449K | 0.36% | 57 |
|
|
2020
Q2 | $487K | Sell |
15,705
-20
| -0.1% | -$679 | 0.1% | 35 |
|
|
2020
Q1 | $487K | Buy |
15,725
+187
| +1% | +$6.37K | 0.15% | 33 |
|
|
2019
Q4 | $578K | Buy |
15,538
+188
| +1% | +$6.7K | 0.17% | 34 |
|
|
2019
Q3 | $523K | Sell |
15,350
-6
| -0% | -$218 | 0.17% | 30 |
|
|
2019
Q2 | $631K | Buy |
15,356
+4,135
| +37% | +$164K | 0.21% | 24 |
|
|
2019
Q1 | $452K | Buy |
11,221
+371
| +3% | +$14.9K | 0.16% | 27 |
|
|
2018
Q4 | $454K | Hold |
10,850
| – | – | 0.16% | 27 |
|
|
2018
Q3 | $454K | Buy |
10,850
+1
| +0% | +$38 | 0.16% | 27 |
|
|
2018
Q2 | $373K | Buy |
10,849
+1
| +0% | +$34 | 0.14% | 28 |
|
|
2018
Q1 | $365K | Buy |
10,848
+1
| +0% | +$34 | 0.14% | 34 |
|
|
2017
Q4 | $373K | Buy |
10,847
+1
| +0% | +$34 | 0.14% | 34 |
|
|
2017
Q3 | $367K | Buy |
10,846
+691
| +7% | +$22.2K | 0.14% | 32 |
|
|
2017
Q2 | $324K | Buy |
10,155
+1
| +0% | +$32 | 0.13% | 34 |
|
|
2017
Q1 | $330K | Buy |
10,154
+1
| +0% | +$32 | 0.14% | 35 |
|
|
2016
Q4 | $313K | Buy |
10,153
+1
| +0% | +$31 | 0.14% | 34 |
|
|
2016
Q3 | $326K | Buy |
10,152
+1
| +0% | +$33 | 0.15% | 32 |
|
|
2016
Q2 | $339K | Sell |
10,151
-1,986
| -16% | -$63.4K | 0.15% | 31 |
|
|
2016
Q1 | $341K | Buy |
12,137
+121
| +1% | +$3.46K | 0.16% | 33 |
|
|
2015
Q4 | $368K | Sell |
12,016
-191
| -2% | -$6.01K | 0.17% | 29 |
|
|
2015
Q3 | $364K | Buy |
12,207
+223
| +2% | +$7.15K | 0.19% | 22 |
|
|
2015
Q2 | $381K | Sell |
11,984
-93
| -0.8% | -$3.03K | 0.19% | 23 |
|
|
2015
Q1 | $399K | Sell |
12,077
-300
| -2% | -$9.54K | 0.2% | 22 |
|
|
2014
Q4 | $366K | Buy |
12,377
+15
| +0.1% | +$430 | 0.2% | 25 |
|
|
2014
Q3 | $347K | Buy |
12,362
+14
| +0.1% | +$393 | 0.2% | 26 |
|
|
2014
Q2 | $348K | Sell |
12,348
-590
| -5% | -$16.8K | 0.19% | 27 |
|
|
2014
Q1 | $394K | Buy |
12,938
+62
| +0.5% | +$1.85K | 0.22% | 26 |
|
|
2013
Q4 | $374K | Sell |
12,876
-364
| -3% | -$10.6K | 0.19% | 27 |
|
|
2013
Q3 | $361K | Hold |
13,240
| – | – | 0.2% | 24 |
|
|
2013
Q2 | $352K | Buy |
+13,240
| New | +$366K | 0.2% | 24 |
|
Other funds holding PFE
Verus Financial Partners's PFE Position: Q2 2026 in Review
Verus Financial Partners increased its Pfizer (PFE) stake by 0.23% in Q2 2026, buying an estimated $549 and bringing the position to 9,013 shares worth $217K. The position accounts for 0.02% of the portfolio, ranked #119.
Verus Financial Partners first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $992K in Q3 2020. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Verus Financial Partners held 9,013 shares of Pfizer worth $217K as of Q2 2026.
- Verus Financial Partners bought 21 Pfizer shares in Q2 2026, an estimated $549.
- Pfizer made up 0.02% of Verus Financial Partners's portfolio in Q2 2026, its #119 holding.
- Verus Financial Partners first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Verus Financial Partners's Pfizer position peaked at $992K in Q3 2020.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Verus Financial Partners's 13F filing for Q2 2026, filed 21 Jul 2026.